Formation of nanosized organic molecular crystals on engineered surfaces
- PMID: 19958030
- DOI: 10.1021/ja908055y
Formation of nanosized organic molecular crystals on engineered surfaces
Abstract
The pharmaceutical industry has great interest in organic molecular nanosized crystals because their enhanced solubility and dissolution rate can potentially enhance drug bioavailability. In this work, patterned engineered surfaces were used to crystallize glycine with a lateral dimension below 200 nm in a confined volume while controlling supersaturation. Bifunctional patterned surfaces with hydrophilic islands, as small as 500 nm, surrounded by hydrophobic regions were prepared using lithography and self assembled monolayers. Individual glycine crystals under 200 nm were formed from the confined solutions wetting each hydrophilic island, while supersaturation was controlled by slow antisolvent diffusion. Individual crystals were characterized with AFM and Raman spectroscopy and determined to be the metastable beta form. The solubility enhancement as a function of crystal size was measured, and the solubility of crystals with a radius of 100 nm or less was estimated.
Similar articles
-
Crystallization on confined engineered surfaces: a method to control crystal size and generate different polymorphs.J Am Chem Soc. 2005 Nov 2;127(43):14982-3. doi: 10.1021/ja055416x. J Am Chem Soc. 2005. PMID: 16248610
-
Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process.Eur J Pharm Biopharm. 2008 Jun;69(2):454-65. doi: 10.1016/j.ejpb.2008.01.007. Epub 2008 Jan 18. Eur J Pharm Biopharm. 2008. PMID: 18359211
-
Labeled gold nanoparticles immobilized at smooth metallic substrates: systematic investigation of surface plasmon resonance and surface-enhanced Raman scattering.J Phys Chem B. 2006 Sep 7;110(35):17444-51. doi: 10.1021/jp0636930. J Phys Chem B. 2006. PMID: 16942083
-
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.Adv Drug Deliv Rev. 2007 Jul 30;59(7):617-30. doi: 10.1016/j.addr.2007.05.011. Epub 2007 May 29. Adv Drug Deliv Rev. 2007. PMID: 17597252 Review.
-
High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.Adv Drug Deliv Rev. 2004 Feb 23;56(3):275-300. doi: 10.1016/j.addr.2003.10.020. Adv Drug Deliv Rev. 2004. PMID: 14962582 Review.
Cited by
-
Formation of Organic Molecular Nanocrystals under Soft Confinement.CrystEngComm. 2015 Aug 21;17(31):6044-6052. doi: 10.1039/C5CE01202C. CrystEngComm. 2015. PMID: 26306076 Free PMC article.
-
Confined crystallization of fenofibrate in nanoporous silica.CrystEngComm. 2015 Nov 7;17(41):7922-7929. doi: 10.1039/C5CE01148E. Epub 2015 Sep 21. CrystEngComm. 2015. PMID: 26778918 Free PMC article.
-
Crystallization of molecular layers produced under confinement onto a surface.Nat Commun. 2024 Mar 5;15(1):2015. doi: 10.1038/s41467-024-45900-0. Nat Commun. 2024. PMID: 38443350 Free PMC article.
-
Electrolyte-Gated Organic Field-Effect Transistors for Quantitative Monitoring of the Molecular Dynamics of Crystallization at the Solid-Liquid Interface.Nano Lett. 2022 Apr 13;22(7):2643-2649. doi: 10.1021/acs.nanolett.1c04424. Epub 2022 Mar 24. Nano Lett. 2022. PMID: 35324207 Free PMC article.
-
Formation of Organic Molecular Nanocrystals under Rigid Confinement with Analysis by Solid State NMR.CrystEngComm. 2014 Oct 21;16(39):9345-9352. doi: 10.1039/C4CE01087F. CrystEngComm. 2014. PMID: 25258590 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous